Oxygense LLC is developing a medical monitoring product which employs chemical and optoelectronic technology for early detection of hemorrhagic shock. Oxygense approached NextFab for assistance in converting their laboratory implementation into a portable version suitable for trials. The challenges included electronics redesign and new board development, optical and optoelectronics redesign and repackaging, new physical user interface design, and development of a sterilizable enclosure system.
NextFab manufactured and delivered 12 prototype units meeting the client's requirements. The devices are currently in trials.